Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

ACR Appropriateness Criteria® acute chest pain - no ECG or enzyme evidence of myocardial ischemia/infarction.

BIBLIOGRAPHIC SOURCE(S)

  • Stanford W, Yucel EK, Bettmann MA, Casciani T, Gomes AS, Grollman JH, Holtzman SR, Polak JF, Sacks D, Schoepf J, Jaff M, Moneta GL, Expert Panel on Cardiovascular Imaging. Acute chest pain: no ECG or enzyme evidence of myocardial ischemia/infarction. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 5 p. [39 references]

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: American College of Radiology (ACR), Expert Panel on Cardiovascular Imaging. Acute chest pain - no ECG evidence of myocardial ischemia/infarction. Reston (VA): American College of Radiology (ACR); 2001. 5 p. (ACR appropriateness criteria).

The appropriateness criteria are reviewed annually and updated by the panels as needed, depending on introduction of new and highly significant scientific evidence.

** REGULATORY ALERT **

FDA WARNING/REGULATORY ALERT

Note from the National Guideline Clearinghouse: This guideline references a drug(s)/intervention(s) for which important revised regulatory and/or warning information has been released.

  • June 8, 2007, Troponin-I Immunoassay: Class I Recall of all lots of the Architect Stat Troponin-I Immunoassay. The assay may report falsely elevated or falsely decreased results at and near a low level, which may impact patient treatment.

BRIEF SUMMARY CONTENT

 ** REGULATORY ALERT **
 RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

ACR Appropriateness Criteria®

Clinical Condition: Acute Chest Pain: No ECG or Enzyme Evidence of Myocardial Ischemia/Infarction

Radiologic Exam Procedure Appropriateness Rating Comments
X-ray, chest 9  
NUC, myocardial perfusion scan 8 If myocardial etiology is suspected.
CT, chest, multi detector (MDCT) 8 Useful to rule out other sources for chest pain such as aortic dissection, pulmonary embolism, etc.
US, transthoracic echocardiography (TTE) 6 If CT is non-diagnostic.
US, transesophageal echocardiography (TEE) 6 To exclude aortic dissection. Especially if MDCT or MRI are not diagnostic and/or not available.
CT, chest, single detector 6  
MRI/MRA, aortic 6  
INV, catheter pulmonary angiography 6 If MDCT is non-diagnostic and pulmonary embolism is suspected.
NUC, V/Q scan 5 May be appropriate if contrast administration is contraindicated.
X-ray, barium swallow and upper GI series 4  
X-ray, rib 4  
X-ray, cervical spine 4  
X-ray, thoracic spine 4  
US, stress echocardiography 4 May be indicated if cardiac etiology is still suspected after negative CXR and MDCT.
US, gall bladder 4  
US, peripheral venous 4  
MRA, pulmonary artery 4  
PET, cardiac 4  
Aortogram, thoracic 4 Unless results of less invasive tests are equivocal.
INV, coronary angiography with LV gram 4 Last choice for evaluation. Only if other tests are equivocal. Depends on noninvasive test.
NUC, bone scan 2  
Appropriateness Criteria Scale
1 2 3 4 5 6 7 8 9
1 = Least appropriate 9 = Most appropriate

Note: Abbreviations used in the table are listed at the end of the "Major Recommendations" field.

Introduction

Patients frequently present to emergency departments with the classical anginal symptoms of chest tightness and left arm pain. If these symptoms are present and if an ECG shows evidence of ischemia, a cardiac etiology for the chest pain is favored. Ischemic pain can also masquerade as indigestion, muscle spasm, or myriad other complaints. Many patients, however, present with chest pain without strong evidence of a cardiac etiology, that is, with a normal or nondiagnostic ECG and serum markers (i.e., troponins). In such patients, other diagnoses need to be considered, and other imaging modalities need to be utilized.

Imaging modalities useful in evaluating patients presenting to the emergency department without ECG or troponin evidence of myocardial infarction/angina, but with suspected cardiac origin for the chest pain are chest film, TEE and TTE, thallium 201 and technetium 99m perfusion studies, positron emission tomography, technetium 99m pyrophosphate infarct avid imaging, radionuclide ventriculography, cardiac catheterization, and the CT determination of coronary calcium. Imaging modalities to evaluate what are thought to be noncardiac causes of chest pain include cervical and thoracic spine films, barium upper GI studies, radionuclide esophageal transit time studies, pulmonary angiography, V/Q scans, CT spine, aortic, and pulmonary artery studies, MRI spine and aortic studies, abdominal ultrasound, and possibly mammography.

Chest Film

The chest film is extremely important in evaluating patients presenting to the emergency room with chest pain, and it is usually the initial imaging study obtained. Plain chest films can be diagnostic in pneumothorax, pneumomediastinum, fractured ribs, acute or chronic infections, and malignancies. Other conditions producing chest pain, such as aortic aneurysms or dissections and pulmonary emboli, may be suspected from the chest film, but the overall sensitivity is very low.

Calcifications may indicate pericardial disease, ventricular aneurysms, intracardiac thrombi, or aortic disease. The presence of a Hampton hump, Westermark sign, or pulmonary artery enlargement may indicate pulmonary embolism. Mediastinal air may indicate a ruptured viscus or rupture of a subpleural bleb.

Transthoracic and Transesophageal Echocardiography

TTE and TEE with or without pharmacologic stress can help define a cardiac origin for chest pain when abnormalities of ventricular wall motion are present. TTE may additionally be helpful in diagnosing pericarditis, pericardial effusion, valvular dysfunction, and/or intracardiac thrombus. TTE is helpful in diagnosing aortic dissection, intracardiac thrombus, and valvular dysfunction. With TEE, the arch of the aorta and the upper abdominal aorta are less well visualized; however, the ascending and descending aorta are usually well seen. In a small number of patients, mitral valve prolapse may be the cause for the chest pain, and this condition could be recognized using transesophageal echocardiography. Pharmacologic stress can add an additional element of risk stratification to the echocardiographic examination, particularly if coronary artery occlusive disease remains a concern.

Conventional, Helical, and Electron Beam Computed Tomography

Conventional CT can be diagnostic in pneumothorax, pneumonia, malignancies, and chronic pulmonary disorders such as fibrosis and granulomatous disease. It can also help to confirm central pulmonary emboli, pulmonary infarcts, and aortic aneurysms and dissections. Complications of aortic aneurysms such as leaks are also identifiable with CT. Pericardial effusions, thickening, and calcifications are readily seen. Electron beam CT and helical CT are additionally helpful by diagnosing coronary artery calcification (atherosclerosis) as the possible cause of the chest pain, although specificity is low. Conversely, the absence of calcium is an excellent indicator of the absence of significant coronary stenosis. Both types of CT have additional utility in defining ventricular aneurysms, wall motion abnormalities, and thrombus resulting from myocardial infarction. CT angiography (CTA) is gaining utility in evaluating coronary stenosis and detecting the presence of anomalous coronary arteries. MDCT is the current standard rather than single-slice CT.

Cervical and Thoracic Spine Films

Films of the cervical and thoracic spine may be indicated to establish vertebral abnormalities (e.g., vertebral body collapse or fracture) as a cause of chest pain.

Radionuclide Studies

Myocardial perfusion studies using thallium 201, technetium 99m sestamibi, or tetrofosmin scintigraphy can identify perfusion abnormalities and help in establishing a cardiac cause for the chest pain.

Radionuclide ventriculography can also help establish a cardiac etiology for the chest pain by demonstrating abnormalities of ventricular wall motion secondary to ischemia/infarction.

Infarct avid imaging with technetium 99m pyrophosphate can identify acute myocardial infarction at 12-36 hours after infarct by showing radioactive tracer uptake at the infarction site.

Positron emission tomography can reliably show myocardial perfusion deficits using N13 ammonia agents and can document anaerobic myocardial metabolism using F18 fluorodeoxyglucose. Again, these tests may be of help in the patient suspected of having a cardiac etiology for the chest pain and in whom the ECG and troponin are nondiagnostic.

Magnetic Resonance

MRI has utility in demonstrating spinal abnormalities and nerve root compression as a cause of chest pain. It also has utility in demonstrating myocardial wall motion abnormalities and/or pericardial thickening and effusion. At times intracardiac thrombi can be seen; however, other tests are usually better for establishing cardiac etiologies as the source of the chest pain. Magnetic resonance perfusion agents can show either a "cold spot" of myocardial infarction with the use of T1 enhancing agents or a "hot spot," using magnetic susceptibility agents. These techniques may be helpful in establishing a cardiac etiology for the chest pain where the ECG and troponin are either negative or nondiagnostic. MR imaging incorporating dobutamine and other pharmacologic stress agents increases sensitivity in determining a cardiac etiology for chest pain.

Cardiac Catheterization

Cardiac catheterization with coronary angiography is the "gold standard" for demonstrating coronary pathology. This is usually the final diagnostic test in defining heart disease, although MDCT has recently shown promise as an accurate noninvasive alternative, particularly if the diagnosis is in question.

Barium Swallow/Endoscopy

Esophageal disorders may be the cause of chest pain in patients presenting to the emergency department with symptoms typical of angina but with negative ECG and troponins. A barium swallow or endoscopy and, in some cases, radionuclide transit studies may be of help in diagnosing esophageal spasm or reflux as an etiology of the chest pain.

Abdominal Plain Films

In limited instances, cholecystitis or cholangitis, renal disease, perforated viscus, or diaphragmatic abnormalities may be an etiology for chest pain. These disorders can often be suspected from an abdominal plain film.

Abdominal Ultrasonography

Abdominal ultrasound may be indicated in establishing cholecystitis as a cause for the chest pain. Ultrasound is also helpful in evaluating pancreatitis and/or abscesses and other fluid collections.

Pulmonary Angiography

Pulmonary angiography had been considered to be the definitive test in patients with suspected pulmonary embolism. Multidetector CT angiography has largely replaced catheter pulmonary angiography. In addition to being noninvasive and having the ability to demonstrate smaller emboli, it has the added advantage of demonstrating other abnormalities that may be the cause of the chest pain, such as neoplasm or pulmonary airspace disease. The ventilation/perfusion scan is rapidly being replaced by MDCT. At times it can be additionally helpful in establishing pulmonary embolism as the etiology for the chest pain, although it is now generally reserved for patients who cannot undergo CT pulmonary angiography.

Mammography

On rare occasions fat necrosis or breast abscess can masquerade as angina. If these conditions are suspected, a mammogram, breast ultrasound, or MR studies may be indicated.

Aortography

As with pulmonary angiography, catheter-based aortography had been considered the definitive imaging procedure in patients with aortic dissection or aneurysmal disease. It has now been almost completely replaced by CTA or MRA, as both are rapid, noninvasive, and able not only to define the aortic lumen but also to characterize the aortic wall and other pathology.

Summary

Although the patient's history is the most important factor in establishing the etiology in patients presenting to the emergency department with chest pain, other imaging modalities are frequently used. The chest film is almost universally obtained; CT, MRI, radionuclide studies, barium swallow, spine studies, plain films, and angiography are useful when specific diagnoses are considered.

Abbreviations

  • CT, computed tomography
  • CXR, chest x-ray
  • ECG, electrocardiogram
  • GI, gastrointestinal
  • INV, invasive
  • LV, left ventricular
  • MDCT, multidetector computed tomography
  • MRA, magnetic resonance angiography
  • MRI, magnetic resonance imaging
  • NUC, nuclear medicine
  • PET, positron emission tomography
  • TEE, transesophageal echocardiography
  • TTE, transthoracic echocardiography
  • US, ultrasound
  • V/Q, ventilation/perfusion scan

CLINICAL ALGORITHM(S)

Algorithms were not developed from criteria guidelines

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The recommendations are based on analysis of the current literature and expert panel consensus.

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • Stanford W, Yucel EK, Bettmann MA, Casciani T, Gomes AS, Grollman JH, Holtzman SR, Polak JF, Sacks D, Schoepf J, Jaff M, Moneta GL, Expert Panel on Cardiovascular Imaging. Acute chest pain: no ECG or enzyme evidence of myocardial ischemia/infarction. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 5 p. [39 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

1998 (revised 2005)

GUIDELINE DEVELOPER(S)

American College of Radiology - Medical Specialty Society

SOURCE(S) OF FUNDING

American College of Radiology (ACR) provided the funding and the resources for these ACR Appropriateness Criteria®.

GUIDELINE COMMITTEE

Committee on Appropriateness Criteria, Expert Panel on Cardiovascular Imaging

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Panel Members: William Stanford, MD; E. Kent Yucel, MD (Panel Chair); Michael A. Bettmann, MD; Thomas Casciani, MD; Antoinette S. Gomes, MD; Julius H. Grollman, MD; Stephen R. Holtzman, MD; Joseph F. Polak, MD, MPH; David Sacks, MD; Joseph Schoepf, MD; Michael Jaff, MD; Gregory L. Moneta, MD

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: American College of Radiology (ACR), Expert Panel on Cardiovascular Imaging. Acute chest pain - no ECG evidence of myocardial ischemia/infarction. Reston (VA): American College of Radiology (ACR); 2001. 5 p. (ACR appropriateness criteria).

The appropriateness criteria are reviewed annually and updated by the panels as needed, depending on introduction of new and highly significant scientific evidence.

GUIDELINE AVAILABILITY

Electronic copies: Available in Portable Document Format (PDF) from the American College of Radiology (ACR) Web site.

ACR Appropriateness Criteria® Anytime, Anywhere™ (PDA application). Available from the ACR Web site.

Print copies: Available from the American College of Radiology, 1891 Preston White Drive, Reston, VA 20191. Telephone: (703) 648-8900.

AVAILABILITY OF COMPANION DOCUMENTS

PATIENT RESOURCES

None available

NGC STATUS

This summary was completed by ECRI on February 20, 2001. The information was verified by the guideline developer on March 14, 2001. This summary was updated by ECRI on July 31, 2002. The updated information was verified by the guideline developer on October 1, 2002. This summary was updated by ECRI on March 17, 2006. This summary was updated by ECRI Institute on July 12, 2007 following the U.S. Food and Drug Administration (FDA) advisory on Troponin-1 Immunoassay.

COPYRIGHT STATEMENT

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo